Influenza B virus (IBV) undergoes continuous genetic mutations that can affect vaccine effectiveness and immune evasion. Although considerable research on IBV epidemiology exists globally, understanding of its genetic behavior in Saudi Arabia remains limited. This study characterized the molecular epidemiology of IBV in Riyadh, Saudi Arabia, during the 2024-2025 influenza season and evaluated compatibility with the current vaccine strain.
Keywords: N-linked glycosylation, influenza B virus, molecular epidemiology, phylogenetic analysis, vaccine effectiveness
Viruses
Journal Article
English
41902266
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.